Biopanib 200mg Tablet

About

Biopanib 200mg Tablet is a targeted therapeutic agent, classified as a tyrosine kinase inhibitor (TKI). Its primary action involves blocking specific intracellular signaling pathways that are critical for the growth, proliferation, and survival of cancer cells. By inhibiting these aberrant kinase activities, Biopanib effectively disrupts the molecular mechanisms driving tumor development and progression. This medication is indicated for the treatment of various types of cancer where specific molecular targets are identified, offering a more precise and personalized approach to oncology. It aims to control disease progression and improve patient outcomes by selectively targeting cancerous cells while sparing healthy tissues to a greater extent than conventional cytotoxic agents. Close medical supervision and regular monitoring are crucial during treatment.

Uses

• Treatment of certain solid tumors with specific genetic alterations.
• Management of advanced or metastatic cancers.
• Inhibition of cancer cell proliferation and survival.
• Used as part of a treatment regimen for targeted cancer therapy.

Directions For Use

Take this medication orally exactly as prescribed by your doctor, typically once daily. Swallow the tablet whole with water; do not crush, chew, or break it.

Benefits

• Provides highly targeted anti-cancer effects.
• Offers the convenience of oral administration.
• Can lead to significant disease control.
• Potentially reduces severe systemic side effects.
• Effective in specific molecularly defined cancers.
• May improve overall quality of life for patients.

Side Effects

• Fatigue
• Diarrhea
• Nausea
• Vomiting
• Skin rash
• Hand-foot syndrome
• Hypertension
• Headache
• Abdominal pain
• Loss of appetite
• Hair thinning
• Elevated liver enzymes

Safety Measures

• Alcohol - It is advisable to avoid or limit alcohol intake due to the potential for increased liver toxicity and gastrointestinal irritation.
• Pregnancy - Contraindicated during pregnancy as it may cause severe harm to the fetus. Women of childbearing potential must use reliable contraception.
• Breastfeeding - Not recommended for breastfeeding mothers as the drug may be excreted in breast milk and pose risks to the infant.
• Liver - Administer with caution in patients with hepatic impairment. Dose adjustments may be necessary, and liver function tests should be monitored regularly.
• Kidney - Use with caution in patients with renal impairment. Dose adjustments may be required, and kidney function should be closely monitored.
• Lung - Patients should be monitored for signs of interstitial lung disease (ILD) or pneumonitis. Discontinue if symptoms develop and manage appropriately.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.